Alexanders Inc. Reports Director Changes and Compensation Updates
Ticker: ALX · Form: 8-K · Filed: Dec 30, 2024 · CIK: 3499
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
Alexanders Inc. swapped a director and updated exec pay. Board changes incoming.
AI Summary
Alexanders Inc. announced on December 30, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of a director and the election of a new director, along with updates to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes and compensation adjustments, which typically carry low immediate risk.
Key Players & Entities
- Alexanders Inc. (company) — Registrant
- December 30, 2024 (date) — Date of Report
FAQ
Who is the departing director and who is the newly elected director?
The filing does not specify the names of the departing or newly elected directors, only that these events occurred.
What specific changes were made to the compensatory arrangements for certain officers?
The filing indicates that there were updates to compensatory arrangements but does not provide specific details on the nature or extent of these changes.
What is the primary reason for the director departure?
The filing does not disclose the reason for the director's departure.
When will the newly elected director officially take their position?
The filing does not specify an effective date for the newly elected director's term, only that the election occurred as of December 30, 2024.
Are there any financial implications mentioned regarding the compensation changes?
No specific financial implications or dollar amounts related to the compensatory arrangements are detailed in this filing.
Filing Stats: 525 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2024-12-30 16:18:03
Key Financial Figures
- $1 — nge on which registered Common Stock, $1 par value per share ALX New York Stoc
Filing Documents
- alx-20241230.htm (8-K) — 30KB
- 0000003499-24-000043.txt ( ) — 151KB
- alx-20241230.xsd (EX-101.SCH) — 2KB
- alx-20241230_lab.xml (EX-101.LAB) — 21KB
- alx-20241230_pre.xml (EX-101.PRE) — 12KB
- alx-20241230_htm.xml (XML) — 3KB
From the Filing
alx-20241230 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2024 ALEXANDERS INC (Exact Name of Registrant as Specified in Charter) Delaware 001-06064 51-0100517 (State or Other (Commission (IRS Employer Jurisdiction of Incorporation) File Number) Identification No.) 210 Route 4 East Paramus, New Jersey 07652 (Address of Principal Executive offices) (Zip Code) Registrant's telephone number, including area code: ( 201 ) 587-8541 Former name or former address, if changed since last report: N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2.): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $1 par value per share ALX New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory On December 30, 2024 , due to health reasons, Dr. Richard West submitted his resignation from the Board of Directors (the "Board") of Alexander's, Inc. (the "Company"), including from his role as Chair of the Audit Committee of the Board (the "Audit Committee") and Chair of the Compensation Committee (the "Compensation Committee"), effective as of January 1, 2025. Effective January 1, 2025, the Board reduced the size of the Board to seven (7) directors, eliminated its Executive Committee and appointed Mandakini Puri as Chair of the Audit Committee and Wendy A. Silverstein as Chair of the Compensation Committee. Dr. West's decision to resign was not the result of any disagreement with management or the Board, on any matter relating to the Company's operations, policies, or practices. The Company is very grateful for Dr. West's extraordinary dedication over the course of his many years of service on the Board. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALEXANDER'S, INC. (Registrant) By: /s/ Gary Hansen Name: Gary Hansen Title: Chief Financial Officer (duly authorized officer and principal financial and accounting officer) Date: December 30, 2024 3